aside from Labskin20 May 2015 01:56
Tony Richardson, CEO of Venn Life Sciences commented: "After five years of dermatological research, testing and consumer trials, this patent grant confirmation from the European Patent office is a substantial step forward in the commercialisation of this unique anti-acne complex.
Should be due an update on this, as the patent was granted a year ago and they did say they were looking to take it to production at the end of 2014.